NASDAQ NMS - GLOBAL MARKET · MEDP
-0.46% · -$2.85 · Vol 522.2K
Market closed · last close 4:00 PM ET · price as of 17:26:33 ET
Medpace Holdings Inc

Medpace Holdings Inc

Life Sciences Tools & Services
$612.33
Card
Relationship Map

Follow $MEDP

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $MEDP by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measuredMethodology
MEDP
Medpace Holdings Inc
Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

56/ 100
Veridion Score
Middle range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: HIGH · 6 of 6 factors measured · Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is MEDP moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading MEDP catalysts
About Medpace Holdings Inc
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Listed since
2016
Employees
7K
Country
US

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$615.41
Day high
$619.41
Day low
$608.54
Previous close
$615.18
52W high
$620.75
-1.36% from high
52W low
$393.42
96% of range
Market cap
$17.1B
P/E
39.53×
EPS
$15.49
Beta
-0.28
Shares out
27.9M
Volume
522.2K
2.46× rel vol
Avg volume
211.9K
VWAP
$612.43
Price history computed in-house
1W
+2.84%
1M
-1.36%
3M
+29.33%
1Y
+22.81%
YTD
+9.02%
SMA 50 $584.79 · above
SMA 200 $520.91 · above
52W position 96%

MEDP overview

Loading financial statements
Loading MEDP Form 4 filings
Public disclosures

Congress activity in MEDP

Federal contracts

MEDP contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for MEDP in this window.
Lobbying spend

MEDP lobbying filings, year to date.

Registered lobbying filings matched to Medpace Holdings Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for MEDP in this window.
Loading news for MEDP
Analyst ratings
Sovereign unlock shows live analyst consensus for MEDP.
Options
Sovereign unlock shows live options positioning for MEDP.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.